Clinical, hormonal and metabolic parameters in the PCO+HA+O and PCO+O groups.

<p>Statistical differences between groups were compared with independent sample <i>t</i>-tests or ANCOVA for continuous variables, and chi-square tests for categorical variables.</p>a<p>Data are shown as means ± SD;</p>b<p>number (%).</p>c<p>Values are age- and BMI-adjusted geometric means (95% CI) for log-transformed variables; adjusted means and 95% CIs were back-transformed. <i>P</i>-values were evaluated by ANCOVA, adjusting for age and BMI.</p>d<p>Diabetes information was available for 546 participants (PCO+HA+O, n = 372; PCO+O, n = 174).</p>e<p>PP2 glucose was available for 682 participants (PCO+HA+O, n = 422; PCO+O, n = 260).</p>f<p>PP2 insulin was available for 646 participants (PCO+HA+O, n = 403; PCO+O, n = 243).</p>g<p>Hemoglobin A_1C was available for 550 participants (PCO+HA+O, n = 372; PCO+O, n = 178).</p><p>BMI, body-mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; mF-G, modified Ferriman–Gallwey; SHBG, sex hormone-binding globulin; FPG, fasting plasma glucose; PP2, postprandial 2 h; HOMA-IR, homeostatic model for insulin resistance; TC, total cholesterol; HDL-C, high density lipoprotein-cholesterol; LDL-C, low density lipoprotein-cholesterol; TG, triglyceride.